Study will evaluate the safety and effectiveness of the OMNYPULSE Pulsed Field Ablation (PFA) platform with integrated mapping
News | Cardiovascular Clinical Studies
Biosense Webster Begins Evaluation of Large-tip Focal Pulsed Field Ablation Catheter in Omny-IRE Clinical Trial in Europe

September 18, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...

Home September 18, 2023
Home
Abelacimab, a Dual-Acting Factor XI / XIa Inhibitor, Demonstrated an Unprecedented Reduction in Bleeding in the Largest and Longest Head-toHead Study Comparing a Factor XI Inhibitor to a DOAC
News | Cardiovascular Clinical Studies
Atrial Fibrillation Study with Abelacimab Stopped Early by the Data Monitoring Committee Due to an Overwhelming Reduction in Bleeding as Compared to a DOAC

September 18, 2023 — Anthos Therapeutics, Inc., a clinical stage company developing innovative therapies for ...

Home September 18, 2023
Home
Investigational device for treating tricuspid valve regurgitation implanted using non-surgical procedure
News | Heart Failure
Henry Ford Health Patient First in the US to Receive New Heart Failure Technology

September 15, 2023 — A team of interventional cardiologists from Henry Ford Health’s Center for Structural Heart Disease ...

Home September 15, 2023
Home
US adults with prior traumatic brain injury (TBI) had an estimated 32% higher stroke risk over a 30-year study period
News | Stroke
Even Mild Head Injury Increases the Risk of Ischemic Stroke, Study Shows

September 15, 2023 — Suffering a traumatic brain injury (TBI) – no matter how severe – is associated with a ...

Home September 15, 2023
Home
They are the only hospitals in New Jersey to earn this elite distinction and provide world-class patient care through a sustainable quality improvement program
News | Cardiovascular Business
Five Hackensack Meridian Hospitals Nationally Recognized for Excellence with ACC HeartCARE Center Designations

September 15, 2023 — The American College of Cardiology (ACC) has recognized five Hackensack Meridian Health hospitals ...

Home September 15, 2023
Home
Contrast enhanced ultrasound (CEUS) is underutilized in the United States
News | Ultrasound Imaging
CEUS Underutilization May Pose Greater Risk Than Rare Side Effects Associated With Use, Say Experts

September 15, 2023 — Contrast enhanced ultrasound (CEUS) is underutilized in the United States, and reduced access to ...

Home September 15, 2023
Home
New therapeutic option has potential to reduce rate of major limb amputation in US
News | Peripheral Artery Disease (PAD)
FDA Approves LimFlow System in Patients with Chronic Limb-threatening Ischemia and No Suitable Endovascular or Surgical Revascularization Options

September 14, 2023 — LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of ...

Home September 14, 2023
Home
First dedicated registry to investigate DCB performance in isolated popliteal artery lesions shows Passeo-18 Lux DCB as beneficial treatment for challenging anatomical segment
News | Drug-Eluting Balloons
BIOLUX P-III BENELUX All-Comers Registry Demonstrates Safety and Efficacy of BIOTRONIK’s Drug-Coated Balloon in Isolated Popliteal Lesions at 24 Months

September 14, 2023 — BIOTRONIK announced the two-year-results from the BIOLUX P-III BENELUX all-comers registry ...

Home September 14, 2023
Home
Reduced inflammation at the site of myocardial infarction and improved heart function demonstrated. Novel therapy to modulate immune response with apoptotic cell-derived nanovesicles
News | Cardiovascular Clinical Studies
Myocardial Infarction, the Number One Cause of Sudden Death, May be Treated by Modulating the Immune Response

September 14, 2023 — Myocardial infarction, the number one cause of sudden death in adults and the number two cause of ...

Home September 14, 2023
Home
University Hospitals Harrington Heart & Vascular Institute first to adopt technology in U.S.
News | Cath Lab
New Study Confirms HeartFlow FFRCT Leads to Improved Patient Outcomes

September 13, 2023 — A diagnostic test, first offered in the United States at University Hospitals (UH) Harrington Heart ...

Home September 13, 2023
Home
Socioeconomic status (education, income, employment status and health insurance) appears to be an uneven predictor of heart health with white adults benefitting the most in comparison to Black, Hispanic and Asian Americans
News | Heart Failure
Ohio State Study Shows Socioeconomic Status May Be An Uneven Predictor of Heart Health

September 13, 2023 — Socioeconomic status (education, income, employment status and health insurance) appears to be an ...

Home September 13, 2023
Home
The Smidt Heart Institute at Cedars-Sinai has earned a prestigious designation for its excellence in adult and pediatric extracorporeal membrane oxygenation
News | ECMO Systems
Smidt Heart Institute’s ECMO Expertise Awarded

September 13, 2023 — The Smidt Heart Institute at Cedars-Sinai has earned a prestigious designation for its excellence ...

Home September 13, 2023
Home
The analysis of the health records found that, on average, participants’ systolic blood pressure increased by up to 1.7 mm Hg in the winter months compared to the summer months
News | Hypertension
Study from AHA Hypertension Scientific Sessions Reports on Cold Weather’s Impact on Treating High Blood Pressure

September 13, 2023 — Blood pressure among patients diagnosed with hypertension appeared to slightly increase, and rates ...

Home September 13, 2023
Home
Mineralys Therapeutics, Inc. has presented final results from the Target-HTN Phase 2 trial of lorundrostat, a highly selective aldosterone synthase inhibitor, in individuals with uncontrolled hypertension (uHTN) and resistant hypertension (rHTN).
News | Cardiovascular Clinical Studies
Mineralys Therapeutics Presents Target-HTN Phase 2 Trial Results at 2023 AHA Hypertension Scientific Sessions

September 12, 2023 — Mineralys Therapeutics, Inc. has presented final results from the Target-HTN Phase 2 trial of ...

Home September 12, 2023
Home
Interim results from SOTERIA open-label extension study represent longest safety and efficacy analysis of sotatercept to date
News | Cardiovascular Clinical Studies
Merck Presents New Analyses Supporting the Promising Potential of Sotatercept, its Investigational Medicine for Adults with Pulmonary Arterial Hypertension (PAH)

September 12, 2023 — Merck announced new analyses from studies of sotatercept, Merck’s novel investigational activin ...

Home September 12, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now